stella
beta
An Investigational Scan (rhPSMA-7.3 PET/CT) for Detecting Biochemically Recurrent Prostate Cancer, ENLIGHTEN Trial — Stella
Recruiting
Back to Biochemically Recurrent Prostate Carcinoma trials
Early Phase 1 — Very small initial tests in humans, typically just a few people, to make sure the treatment is safe enough to study further.
Trial locations
(1 site)
United States
Northwestern University, Chicago, Illinois
View full record on ClinicalTrials.gov